El sector sanitario pone a prueba su resiliencia con los aranceles: ¿está infravalorado? https://t.co/EeCFWn8x96
Health Care is getting absolutely torched right now. 🚑 This chart shows the sector underperforming $SPY at its worst pace since the Global Financial Crisis. Long-term opportunity to DCA into a laggard? Top $XLV holdings: $LLY, $JNJ, $ABBV, $UNH, $ABT. https://t.co/lzw4Oil28B
$XLV https://t.co/NVi7bg4YxE
The industrials sector, represented by the $XLI ETF, is approaching an all-time high, indicating strong performance in that area of the market. In contrast, the healthcare sector, tracked by the $XLV ETF, is experiencing significant underperformance, currently at its worst relative to the S&P 500 since the Global Financial Crisis. This downturn is putting pressure on healthcare shares overall, although some stocks within the sector are distinguishing themselves from the broader trend. The top holdings in the $XLV ETF include Eli Lilly (LLY), Johnson & Johnson (JNJ), AbbVie (ABBV), UnitedHealth Group (UNH), and Abbott Laboratories (ABT). Recent discussions suggest the healthcare sector is being tested by tariffs, raising questions about whether it is undervalued amid these challenges.
